Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

570 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Zygomycosis in the 1990s in a tertiary-care cancer center.
Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Kontoyiannis DP, et al. Clin Infect Dis. 2000 Jun;30(6):851-6. doi: 10.1086/313803. Epub 2000 Jun 13. Clin Infect Dis. 2000. PMID: 10852735
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.
Kantarjian HM, Talpaz M, Kontoyiannis D, Gutterman J, Keating MJ, Estey EH, O'Brien S, Rios MB, Beran M, Deisseroth A. Kantarjian HM, et al. Among authors: kontoyiannis d. J Clin Oncol. 1992 Mar;10(3):398-405. doi: 10.1200/JCO.1992.10.3.398. J Clin Oncol. 1992. PMID: 1740679
Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections.
Anaissie EJ, Kontoyiannis DP, Huls C, Vartivarian SE, Karl C, Prince RA, Bosso J, Bodey GP. Anaissie EJ, et al. Among authors: kontoyiannis dp. J Infect Dis. 1995 Aug;172(2):599-602. doi: 10.1093/infdis/172.2.599. J Infect Dis. 1995. PMID: 7622915 Clinical Trial.
Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections.
Anaissie E, Samonis G, Kontoyiannis D, Costerton J, Sabharwal U, Bodey G, Raad I. Anaissie E, et al. Among authors: kontoyiannis d. Eur J Clin Microbiol Infect Dis. 1995 Feb;14(2):134-7. doi: 10.1007/BF02111873. Eur J Clin Microbiol Infect Dis. 1995. PMID: 7758480
Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304.
Anaissie EJ, Kontoyiannis DP, Vartivarian S, Kantarjian HM, O'Brien S, Giralt SA, Andersson BS, Karl C, Champlin RE, Bodey GP. Anaissie EJ, et al. Among authors: kontoyiannis dp. Clin Infect Dis. 1993 Dec;17(6):1022-31. doi: 10.1093/clinids/17.6.1022. Clin Infect Dis. 1993. PMID: 8110925 Clinical Trial.
Primary septicemia caused by Vibrio cholerae non-O1 acquired on Cape Cod, Massachusetts.
Kontoyiannis DP, Calia KE, Basgoz N, Calderwood SB. Kontoyiannis DP, et al. Clin Infect Dis. 1995 Nov;21(5):1330-3. doi: 10.1093/clinids/21.5.1330. Clin Infect Dis. 1995. PMID: 8589171
Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.
Anaissie EJ, Vartivarian SE, Abi-Said D, Uzun O, Pinczowski H, Kontoyiannis DP, Khoury P, Papadakis K, Gardner A, Raad II, Gilbreath J, Bodey GP. Anaissie EJ, et al. Among authors: kontoyiannis dp. Am J Med. 1996 Aug;101(2):170-6. doi: 10.1016/s0002-9343(96)80072-6. Am J Med. 1996. PMID: 8757357 Clinical Trial.
Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature.
Anaissie EJ, Darouiche RO, Abi-Said D, Uzun O, Mera J, Gentry LO, Williams T, Kontoyiannis DP, Karl CL, Bodey GP. Anaissie EJ, et al. Among authors: kontoyiannis dp. Clin Infect Dis. 1996 Nov;23(5):964-72. doi: 10.1093/clinids/23.5.964. Clin Infect Dis. 1996. PMID: 8922787 Review.
Overexpression of Erg11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae.
Kontoyiannis DP, Sagar N, Hirschi KD. Kontoyiannis DP, et al. Antimicrob Agents Chemother. 1999 Nov;43(11):2798-800. doi: 10.1128/AAC.43.11.2798. Antimicrob Agents Chemother. 1999. PMID: 10543768 Free PMC article.
Significance of aspergillemia in patients with cancer: a 10-year study.
Kontoyiannis DP, Sumoza D, Tarrand J, Bodey GP, Storey R, Raad II. Kontoyiannis DP, et al. Clin Infect Dis. 2000 Jul;31(1):188-9. doi: 10.1086/313918. Clin Infect Dis. 2000. PMID: 10913421
570 results
Jump to page
Feedback